Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Virology|February 1, 1995
The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infectionM E Rogel, L I Wu, M EmermanJournal of Biosciences|December 13, 2017
Re-engineering the two-component systems as light-regulated in Escherichia coliSiya Ma, Siwei Luo, L I Wu, et al.Journal of Virology|June 1, 1997
Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrestL Selig, S Benichou, M E Rogel, et al.Molecular Cell|June 8, 2001
HIV-1 infection requires a functional integrase NLSM Bouyac-Bertoia, J D Dvorin, R A Fouchier, et al.Virology|June 23, 1997
Indicator cell lines for detection of primary strains of human and simian immunodeficiency virusesM A Vodicka, W C Goh, L I Wu, et al.Journal of Medicinal Chemistry|August 28, 1998
New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 positionJ M Janusz, P A Young, J M Ridgeway, et al.Journal of Medicinal Chemistry|April 17, 1998
New cyclooxygenase-2/5-lipoxygenase inhibitors. 2. 7-tert-butyl-2,3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations of the dihydrobenzofuran ringJ M Janusz, P A Young, M W Scherz, et al.Journal of Medicinal Chemistry|April 17, 1998
New cyclooxygenase-2/5-lipoxygenase inhibitors. 1. 7-tert-buty1-2,3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: discovery and variation of the 5-keto substituentJ M Janusz, P A Young, J M Ridgeway, et al.Pageof 1